KDM2A and lung cancer: This has been shown for lung cancer, in which alterations in histone lysine methylation are associated with clinical prognosis.17 The H3K36 demethylase KDM2A has been shown to be frequently upregulated in non–small cell lung cancer tumors and to promote tumor growth and invasiveness.18